Livestock S2 vaccine immunity and Brucella melitensis/abortus infection IELISA (enzyme linked immunosorbent assay) detection reagent
A technology of Brucella bovis and detection reagent, which is applied in the fields of genetic engineering and immunology, can solve the problem of inability to identify and immunize herds to purify naturally infected animals with Brucella, and it is impossible to distinguish between immunization and immunization of Brucella vaccine. Natural infection and other problems, to achieve high specificity, sensitivity, and good repeatability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0040] Cloning, prokaryotic expression of embodiment 1S2 vaccine strain gene GL_0002189 and Brucella BP26 gene
[0041] Through the whole genome sequencing of the S2 vaccine strain, the predicted coding gene is compared with the published Brucella genome data to find out the S2-specific genes compared with the sheep and bovine Brucella, and use the PCR method to extract the S2 genome The specific gene GL_0002189 (SeqIDNo.2) of the S2 vaccine strain was amplified in the vaccine strain, and the Brucella BP26 gene (SeqIDNo.3) was used as the control gene. After cloning and sequencing, it was constructed into the prokaryotic expression vector pET30 and transformed into E. coliBL21(DE3) was induced to express, and the immunogenicity of the two recombinant proteins GL_0002189 and BP26 was verified by western-blotting method.
[0042] 1.1 Experimental method:
[0043] 1.1.1 Primer design
[0044] According to the GL_0002189 and BP26 gene sequences, Oligo6.0 was used to design prime...
Embodiment 2I
[0120] Embodiment 2IELISA distinguishes the method that domestic animal S2 vaccine immunity and sheep / bovine breed Brucella infect
[0121] 2.1 Experimental method
[0122] 2.1.1 Determination of the optimal coating concentration of antigen and the optimal dilution of serum
[0123] According to the checkerboard titration method, the two recombinant proteins purified in Example 1 were diluted with the coating solution. The dilution gradients were 1:25, 1:50, 1:100, and 1:200. The initial concentrations of the antigens were respectively For GL_0002189 (0.421mg / mL) and BP26 (0.553mg / ml), add 100μl to each well, coat overnight at 4°C, discard the liquid in the well the next day, wash with washing solution three times, let stand for 5min each time, wash Pat dry the liquid in the wells of the microtiter plate after finishing. Add 100 μl of blocking solution to each well, place at 37°C for 2 hours, wash with washing solution three times, let stand for 5 minutes each time, and pat ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com